Neurology Critical Care
| Principal Investigator/Contact Information | Protocol Title | Patient Population | Recruitment Period |
| Principal Investigator: Nobl Barazangi, MD Contact: Jessica Redford, RN 415-600-1781 | A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection inAcute Ischemic Stroke --ALIAS Visit this study on ClinicalTrials.gov. | Patients less than 84 years in age with acute ischemic stroke | Open |
| Principal Investigator: Jeffrey Thomas, MD Contact: Jessica Redford, RN 415-600-1781 | Intrathecal sodium nitroprusside and thiosulfate (Collateron G1) for the treatment and prevention of cerebral ischemia by augmentation of cerebral blood flow in patients at risk for ischemic stroke following aneurysmal subarachnoid hemorrhage – CG1 | Patients who have had surgical repair of ruptured cerebral aneurysm | Open |
| Principal Investigator: Nobl Barazangi, MD Contact: Jessica Redford, RN 415-600-1781 | The Rapid Anticonvulsant Medication Prior to Arrival Trial - RAMPART Visit this study on ClinicalTrials.gov. | Patients who require treatment by paramedics for status epilepticus | Open |
updated 11/30/09
Back to top

